PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 58 filers reported holding PSYCHEMEDICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $113,000 | – | 5,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 330,392 | $3,010,000 | 2.56% |
| Gs Investments, Inc. | 15,300 | $139,383,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 376,114 | $3,426,000 | 0.08% |
| North Star Investment Management Corp. | 80,119 | $730,000 | 0.08% |
| RBF Capital, LLC | 78,495 | $715,000 | 0.08% |
| CRAWFORD INVESTMENT COUNSEL INC | 305,566 | $2,784,000 | 0.08% |
| CONNORS INVESTOR SERVICES INC | 18,360 | $167,000 | 0.02% |
| Moors & Cabot, Inc. | 19,591 | $182,000 | 0.02% |
| DEPRINCE RACE & ZOLLO INC | 43,754 | $399,000 | 0.01% |
| Ancora Advisors LLC | 19,861 | $181,000 | 0.01% |